Shanghai MicroPort MedBot (HKG:2252) expects to post a net profit of about 28 million yuan to 40 million yuan for the first half, compared with a net loss of 115 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.
The company expects first-half revenue to increase about 200% to 230% year over year, driven by strong sales growth of its Toumai laparoscopic surgical robot in domestic and overseas markets.
MicroPort MedBot said the turnaround to profit was also supported by an improvement of more than 15 percentage points in gross profit margin.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments